Metformin and hepatic carcinogenesis.


Retrospective, hypothesis-generating population studies suggest that diabetics treated with metformin have a substantially reduced risk of several cancers, including hepatoma, relative to diabetics on other therapies. In this issue of the journal (beginning on page 544), Bhalla and colleagues contribute to the growing literature on metformin effects in… (More)
DOI: 10.1158/1940-6207.CAPR-12-0080


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics